BusinessRising visa costs may pinch TCS, Infosys profits
ADVERTISEMENT
Rising visa costs may pinch TCS, Infosys profits
Researchers think a vaccine that can coax the body into making these antibodies before HIV exposure would offer a powerful foil to many forms of the virus.
Indian IT companies, including market leaders TCS and Infosys, may have to bear huge costs towards employee visa fees going ahead, which in turn can put pressure on their profit margins.